{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-048158","form_type":"8-K","ticker":"BAX","cik":"0000010456","company_name":"BAXTER INTERNATIONAL INC","filed_at":"2026-07-14T20:15:49+00:00","discovered_at":"2026-07-14T20:17:00.417212+00:00","generated_at":"2026-07-14T20:17:07.925274+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Baxter changes reportable segments to two: MPT and HST, effective Q2 2026","bullets":["Former Pharmaceuticals segment moved into Infusion Therapies & Platforms division of MPT.","Certain manufacturing facility sales previously in Other now reported in ITP division.","Corporate cost allocation updated: some shared expenses now remain unallocated.","Recast historical segment data for 2024, 2025, and Q1 2026 provided in Exhibit 99.1.","No impact on consolidated net income, EPS, total assets, or stockholders' equity."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-048158","json":"https://secwatch.observer/filing/0001628280-26-048158.json","markdown":"https://secwatch.observer/filing/0001628280-26-048158.md","text":"https://secwatch.observer/filing/0001628280-26-048158.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/10456/000162828026048158/0001628280-26-048158-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/10456/000162828026048158/bax-20260714.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-14T20:17:07.925274+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}